HAWTHORNE, N.Y., March 15 (UPI) -- Taro said Wednesday it has been approved to market generic Elocon Lotion, a corticosteroid to treat skin inflammation. The company said the Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results